CROI 2018 ARV Therapies and Therapeutic Strategies

  CROI2018_Dinner_Banner_v1

CROI2018_Dinner_Register_button

About the Program:

Program Overview:

The ARV Therapies and Therapeutic Strategies program is a comprehensive, independent review of the 25th Conference on Retroviruses and Opportunistic Infections (CROI 2018). This program consists of three components: (1) CME Internet Symposium: CROI 2018 Expert Review: a 1.5 hour Internet symposium that features an overview and discussion of key presentations and posters, selected by the expert faculty discussants; (2) Rapid-Fire Review of CROI 2018: a podcast that provides a brief, audio summary of the most essential data presented at the conference; and (3) From Conference to Clinic: Reviewing and Applying Data From CROI 2018: case-based dinner meetings during which the key data are reviewed, discussed and applied to patient care.

From Conference to Clinic: Reviewing and Applying Data From CROI 2018 is an interactive, case-based dinner program series designed to highlight and discuss the clinical significance and application of new findings in HIV medicine presented at CROI 2018. Because the focus of the dinner programs will be on case studies and applying the data presented at CROI 2018 in a clinical setting, prior to attending a dinner program participants will be asked to view the CME Internet Symposium: CROI 2018 Expert Review, which will familiarize them with the CROI 2018 data and serve as a comprehensive conference overview and summary. As a result of this blended learning approach, participants will gain an increased understanding of key data presented at CROI 2018 and be better prepared to address their HIV patients' health needs and provide optimal care in a clinical setting.

All online components of the program will be accessible at www.viraled.com

This program is produced by the Postgraduate Institute for Medicine and ViralEd, Inc. It is not a session created by or presented at CROI 2018 and it is not sanctioned by the organizers of CROI 2018. 

Back to Top

Target Audience:

This activity has been designed to meet the educational needs of physicians, physician assistants, advanced practice nurses and other health care professionals involved in the care of patients with HIV infection.

Back to Top

Educational Objectives:

After completing this activity, the participant should be better able to:

  • Review data reported at CROI 2018 for counseling, testing and antiretroviral treatment to prevent HIV infection, especially in underserved communities

  • Relate in a clinical setting, findings from key studies on HIV/AIDS diagnosis, management, and treatment presented at CROI 2018
  • Employ strategies based on studies and data presented at CROI 2018 for helping HIV-positive patients in medically underserved communities link to and stay in appropriate and effective HIV care

  • Discuss with patients and colleagues the studies and data on therapies for HIV/AIDS presented at CROI 2018 and use that discussion to decide on appropriate planning of therapy for patients with HIV/AIDS

Back to Top

Program Dates and Locations:

Wednesday, March 14, 2018
Oakland, CA

Thursday, March 22, 2018
Los Angeles, CA

Thursday, March 15, 2018
Chicago, IL
Tuesday, March 27, 2018
Miami, FL
Thursday, March 15, 2018
Houston, TX

Wednesday, March 28th, 2018
Brooklyn, NY

Please note that the 3/21 date has been posponed until 3/28 due to inclement weather

Tuesday, March 20, 2018
Phoenix, AZ
Thursday, March 29, 2018
Jackson, MS
Back to Top 

Schedule for All Programs:

6:00 - 6:30 PM: Check-in/Walk-in Registration

6:30 - 8:30 PM: Program and Q&A

Program Faculty:

Roberto C. Arduino, MD
Professor of Medicine
UT Director of Research, Thomas Street Clinic
The University of Texas-Houston
Houston, Texas 

Jeffrey Burack, MD
Co-Medical Director
East Bay AIDS Center
Oakland, California

Dushyantha T. Jayaweera, MD
University of Miami
Miami, Florida 

Anthony Mills, MD
Southern California Men's Medical Group
Los Angeles, California

Michael Sension, MD
CAN Community Health
Ft. Lauderdale, Florida 

Renslow Sherer, MD
Professor of Medicine
Section of Infectious Diseases and Global Health
University of Chicago
Chicago, Illinois

Antonio E. Urbina, MD
Medical Director
Institute for Advanced Medicine
Mt. Sinai St. Luke's and Mt. Sinai Roosevelt Hospitals
New York, New York 

 
Back to Top

Joint Accreditation Statement:

Jointly-Accredited-Provider-TM_1000x636  In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and ViralEd, Inc. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The Postgraduate Institute for Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Back to Top

Disclosure of Conflicts of Interest:

The Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity.

Back to Top

Sunshine Act:

As of August 1, 2013, pharmaceutical companies are required by the open payments act (AKA Sunshine Act) to account for certain transfers of value provided to physicians. The federal guidance for the Sunshine Act provides exceptions for CME expenses that meet certain criteria. We believe the program to which you are invited meets these exceptions, and therefore we will not be collecting, nor reporting, any information gathered from this program. If federal guidance is further clarified in the future, we will then provide that information to the supporting pharmaceutical companies to the best of our ability.

Back to Top

PIM_small

VE logo 300px 

 

This activity is supported by an independent educational grant from Gilead Sciences Medical Affairs.
This coverage is not sanctioned by the conference organizers and is not an official part of the conference proceedings.

 


Prepare to print

Share this page:

Get link code to this page                     


Back to Top